abstract |
PCT No. PCT/US95/16450 Sec. 371 Date Jul. 30, 1997 Sec. 102(e) Date Jul. 30, 1997 PCT Filed Dec. 4, 1995 PCT Pub. No. WO96/17620 PCT Pub. Date Jun. 13, 1996The invention provides the use of a protein selected from the B-oligomer of pertussis toxin, an individual subunit S2, S3, S4 or S5 thereof, or a combination of the subunits, for the preparation of pharmaceutical compositions comprising them for the treatment of autoimmune diseases. |